Follow us on

It has warned that the identified syrups commonly used to treat cold, flu, and cough symptoms, have been linked to cases of severe illness and child fatalities and could cause severe and potentially life-threatening illnesses.

The global health body has urged authorities worldwide to report to the agency if any of these products are detected in their countries. The Organisation said that such medications should not be prescribed or dispensed to children below two years of age and are generally not recommended for those under five.

The WHO has identified specific batches of Coldrif from Sresan Pharmaceuticals, Respifresh TR from Rednex Pharmaceuticals, and ReLife from Shape Pharma as the affected medicines.

The products identified in this alert are considered substandard as

See Full Page